☰

Erika Augustine - Publications

Affiliations: 
University of Rochester, Rochester, NY 
Tree Info Grants Similar researchers PubMed Report error

60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Schulz A, Patel N, Brudvig JJ, Stehr F, Weimer JM, Augustine EF. The parent and family impact of CLN3 disease: an observational survey-based study. Orphanet Journal of Rare Diseases. 19: 125. PMID 38500130 DOI: 10.1186/s13023-024-03119-8  0.369
2024 Brima T, Freedman EG, Prinsloo KD, Augustine EF, Adams HR, Wang KH, Mink JW, Shaw LH, Mantel EP, Foxe JJ. Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): an auditory evoked potential study of the duration-evoked mismatch negativity (MMN). Journal of Neurodevelopmental Disorders. 16: 3. PMID 38183037 DOI: 10.1186/s11689-023-09515-8  0.506
2023 Brima T, Freedman EG, Prinsloo KD, Augustine EF, Adams HR, Wang KH, Mink JW, Shaw LH, Mantel EP, Foxe JJ. Assessing the integrity of auditory sensory memory processing in CLN3 disease (Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)): An auditory evoked potential study of the duration-evoked mismatch negativity (MMN). Research Square. PMID 37645970 DOI: 10.21203/rs.3.rs-3203894/v1  0.48
2023 Lewin AB, Murphy TK, Mink JW, Small BJ, Adams HR, Brennan E, Augustine EF, Vermilion J, Vierhile A, Collins A, Kudryk K, Dickinson S, Danielson ML, Bitsko RH. Brief youth self-report screener for tics: Can a subscale of the Motor tic, Obsession and compulsion, and Vocal tic Evaluation Survey (MOVES) identify tic disorders in youth? Evidence-Based Practice in Child and Adolescent Mental Health. 8: 1-11. PMID 37323827 DOI: 10.1080/23794925.2023.2191354  0.492
2023 Sapozhnikov Y, Mink JW, Augustine EF, Adams HR, Vierhile A, Lewin AB, Collins AT, McDermott MP, O'Connor T, Kurlan R, Murphy TK, Vermilion J. Teacher Knowledge of Tourette Syndrome and Associated Factors. Pediatric Neurology. 145: 80-87. PMID 37295059 DOI: 10.1016/j.pediatrneurol.2023.05.007  0.382
2021 Vermilion J, Augustine EF, Adams HR, Vierhile A, Collins AT, McDermott MP, O'Connor TG, Kurlan R, van Wijngaarden E, Mink JW. Risk Behaviors in Youth With and Without Tourette Syndrome. Pediatric Neurology. 126: 20-25. PMID 34736059 DOI: 10.1016/j.pediatrneurol.2021.10.007  0.391
2021 Masten MC, Augustine EF, Mink JW. Challenges of Phenotype-Genotype Correlations in Rare Diseases. Jama Ophthalmology. 139: 1323. PMID 34709366 DOI: 10.1001/jamaophthalmol.2021.4372  0.518
2021 Masten MC, Corre C, Paciorkowski AR, Vierhile A, Adams HR, Vermilion J, Zimmerman GA, Augustine EF, Mink JW. A Diagnostic Confidence Scheme for CLN3 Disease. Journal of Inherited Metabolic Disease. PMID 34453334 DOI: 10.1002/jimd.12429  0.558
2021 Augustine EF, Adams HR, de Los Reyes E, Drago K, Frazier M, Guelbert N, Laine M, Levin T, Mink JW, Nickel M, Peifer D, Schulz A, Simonati A, Topcu M, Turunen JA, et al. Management of CLN1 Disease: International Clinical Consensus. Pediatric Neurology. 120: 38-51. PMID 34000449 DOI: 10.1016/j.pediatrneurol.2021.04.002  0.585
2021 Tang C, Han J, Dalvi S, Manian K, Winschel L, Volland S, Soto CA, Galloway CA, Spencer W, Roll M, Milliner C, Bonilha VL, Johnson TB, Latchney L, Weimer JM, ... Augustine EF, et al. A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor-RPE interface. Communications Biology. 4: 161. PMID 33547385 DOI: 10.1038/s42003-021-01682-5  0.496
2021 Masten MC, Vierhile A, Vermilion J, Adams H, Zimmerman GA, Corre C, Mink JW, Augustine EF. Diagnostic confidence for CLN3 disease Molecular Genetics and Metabolism. 132: S70. DOI: 10.1016/J.YMGME.2020.12.161  0.325
2020 Masten MC, Mink JW, Augustine EF. Batten disease: an expert update on agents in preclinical and clinical trials. Expert Opinion On Investigational Drugs. 1-6. PMID 33135495 DOI: 10.1080/13543784.2020.1837110  0.512
2020 de Los Reyes E, Lehwald L, Augustine EF, Berry-Kravis E, Butler K, Cormier N, Demarest S, Lu S, Madden J, Olaya J, See S, Vierhile A, Wheless JW, Yang A, Cohen-Pfeffer J, et al. Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US Clinics. Pediatric Neurology. PMID 32684372 DOI: 10.1016/J.Pediatrneurol.2020.04.018  0.326
2020 Vermilion J, Pedraza C, Augustine EF, Adams HR, Vierhile A, Lewin AB, Collins AT, McDermott MP, O'Connor T, Kurlan R, van Wijngaarden E, Murphy TK, Mink JW. Anxiety Symptoms Differ in Youth With and Without Tic Disorders. Child Psychiatry and Human Development. PMID 32519083 DOI: 10.1007/S10578-020-01012-6  0.463
2020 Masten MC, Williams JD, Vermilion J, Adams HR, Vierhile A, Collins A, Marshall FJ, Augustine EF, Mink JW. The CLN3 disease staging system: A new tool for clinical research in Batten disease. Neurology. PMID 32300063 DOI: 10.1212/Wnl.0000000000009454  0.571
2020 Zimmerman G, Vierhile A, Adams H, Mink J, Augustine E. Methods for quantitative gait analysis in CLN3 disease Molecular Genetics and Metabolism. 129: S166. DOI: 10.1016/J.Ymgme.2019.11.444  0.518
2020 Mink JW, Masten MC, Vermilion J, Adams HR, Vierhile A, Marshall FJ, Beck CA, Augustine EF. Cross-sectional and longitudinal quantification of CLN3 disease progression Molecular Genetics and Metabolism. 129: S109-S110. DOI: 10.1016/J.Ymgme.2019.11.282  0.486
2020 Masten MC, Williams JD, Augustine EF, Vermilion J, Adams HR, Vierhile A, Thatcher A, Marshall FJ, Mink JW. The CLN3 Disease Staging System (CLN3SS): A tool for stratification based on disease severity Molecular Genetics and Metabolism. 129: S106. DOI: 10.1016/J.Ymgme.2019.11.271  0.554
2020 Masten MC, Vermilion J, Adams HR, Vierhile A, Marshall FJ, Beck CA, Augustine EF, Mink JW. Age-at-onset of core features of CLN3 disease: A cross-sectional and longitudinal natural history study Molecular Genetics and Metabolism. 129: S105-S106. DOI: 10.1016/J.Ymgme.2019.11.270  0.476
2020 Masten MC, Thatcher A, Bonifacio K, Vierhile A, Adams HR, Mink JW, Augustine EF. CLN1 disease natural history data: Prospective and retrospective analysis Molecular Genetics and Metabolism. 129: S105. DOI: 10.1016/J.Ymgme.2019.11.269  0.529
2020 Masten MC, Adams HR, Vierhile A, Augustine EF, Mink JW. Hamburg Late Infantile neuronal ceroid lipofucinosis scale (H-LINCLS) vs. the Unified Batten Disease Rating Scale (UBDRS): Comparison and cross-validation Molecular Genetics and Metabolism. 129: S105. DOI: 10.1016/J.Ymgme.2019.11.268  0.485
2020 Adams HR, Beck C, Bonifacio KP, Marshall FJ, Masten M, Thatcher A, Vermilion J, Vierhile A, Augustine EF, Mink JW. Cross-validation of the Vineland-III with independent assessments of cognition and adaptive skills in CLN3 disease Molecular Genetics and Metabolism. 129: S17-S18. DOI: 10.1016/J.Ymgme.2019.11.014  0.482
2019 Vermilion J, Augustine E, Adams HR, Vierhile A, Lewin AB, Thatcher A, McDermott MP, O'Connor T, Kurlan R, van Wijngaarden E, Murphy TK, Mink JW. Tic Disorders are Associated With Lower Child and Parent Quality of Life and Worse Family Functioning. Pediatric Neurology. PMID 32029331 DOI: 10.1016/J.Pediatrneurol.2019.12.003  0.468
2019 Adams HR, Defendorf S, Vierhile A, Mink JW, Marshall FJ, Augustine EF. A novel, hybrid, single- and multi-site clinical trial design for CLN3 disease, an ultra-rare lysosomal storage disorder. Clinical Trials (London, England). 1740774519855715. PMID 31184505 DOI: 10.1177/1740774519855715  0.528
2019 Bitsko R, Adams HR, Holbrook J, Jones C, Augustine E, Mink J, Wijngaarden Ev, Vierhile A, Morrison P, Fisher PW. 2.50 DIAGNOSTIC INTERVIEW SCHEDULE FOR CHILDREN, VERSION 5 (DISC-5): DEVELOPMENT AND VALIDATION OF ADHD AND TIC DISORDER MODULES Journal of the American Academy of Child & Adolescent Psychiatry. 58: S187. DOI: 10.1016/J.Jaac.2019.08.142  0.463
2018 Augustine EF, Beck CA, Adams HR, Defendorf S, Vierhile A, Timm D, Weimer JM, Mink JW, Marshall FJ. Short-Term Administration of Mycophenolate Is Well-Tolerated in CLN3 Disease (Juvenile Neuronal Ceroid Lipofuscinosis). Jimd Reports. PMID 29923092 DOI: 10.1007/8904_2018_113  0.508
2018 Mink JW, Williams JD, Augustine EF. A proposed staging system for CLN3 disease (juvenile Batten disease) Molecular Genetics and Metabolism. 123: S96. DOI: 10.1016/J.Ymgme.2017.12.251  0.542
2018 Adams HR, Mink J, Augustine E, Bitsko RH, Holbrook J, Vierhile A, Morrison P, Bonifacio K, vanWijngaarden E. 36.2 Improving Identification of Tic Disorders Journal of the American Academy of Child & Adolescent Psychiatry. 57: S326. DOI: 10.1016/J.Jaac.2018.07.825  0.447
2017 Augustine EF, Adams HR, Mink JW. Screening tools for tic disorders-Focus on development or implementation? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28436544 DOI: 10.1002/Mds.26981  0.431
2017 Cozart EJ, Augustine EF, Mink JW, Thatcher AR, Adams HR. Batten disease and parents: marital quality, support, and communication Journal of International Child Neurology Association. DOI: 10.17724/Jicna.2017.114  0.487
2016 Augustine EF, Adams HR, Bitsko RH, van Wijngaarden E, Claussen AH, Thatcher A, Hanks CE, Lewin AB, O'Connor TG, Vierhile A, Danielson ML, Kurlan R, Murphy TK, Mink JW. Design of a Multisite Study Assessing the Impact of Tic Disorders on Individuals, Families, and Communities. Pediatric Neurology. PMID 28254245 DOI: 10.1016/J.Pediatrneurol.2016.10.017  0.493
2016 Augustine EF, Mink JW. Juvenile NCL (CLN3 Disease): Emerging Disease-Modifying Therapeutic Strategies. Pediatric Endocrinology Reviews : Per. 13: 655-62. PMID 27491213  0.549
2016 McGuire J, Hanks CE, Mink JW, Adams HR, Augustine EF, Vierhile AE, Thatcher A, Lewin AB, Murphy TK. 1.1 Suicidal Thoughts and Behaviors in Children and Adolescents With Chronic Tic Disorders Journal of the American Academy of Child and Adolescent Psychiatry. 55. DOI: 10.1016/J.Jaac.2016.07.120  0.451
2015 Ragbeer SN, Augustine EF, Mink JW, Thatcher AR, Vierhile AE, Adams HR. Remote Assessment of Cognitive Function in Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease): A Pilot Study of Feasibility and Reliability. Journal of Child Neurology. PMID 26336202 DOI: 10.1177/0883073815600863  0.546
2015 Storch EA, Hanks CE, Mink JW, McGuire JF, Adams HR, Augustine EF, Vierhile A, Thatcher A, Bitsko R, Lewin AB, Murphy TK. SUICIDAL THOUGHTS AND BEHAVIORS IN CHILDREN AND ADOLESCENTS WITH CHRONIC TIC DISORDERS. Depression and Anxiety. PMID 25711415 DOI: 10.1002/Da.22357  0.483
2015 Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG, Boyd J, Cambi F, Chou K, Christine CW, et al. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. Jama. 313: 584-93. PMID 25668262 DOI: 10.1001/Jama.2015.120  0.318
2015 Augustine EF, Adams HR, Beck CA, Vierhile A, Kwon J, Rothberg PG, Marshall F, Block R, Dolan J, Mink JW. Standardized assessment of seizures in patients with juvenile neuronal ceroid lipofuscinosis. Developmental Medicine and Child Neurology. 57: 366-71. PMID 25387857 DOI: 10.1111/Dmcn.12634  0.427
2014 Lewin AB, Mink JW, Bitsko RH, Holbrook JR, Parker-Athill EC, Hanks C, Storch EA, Augustine EF, Adams HR, Vierhile AE, Thatcher AR, Murphy TK. Utility of the diagnostic interview schedule for children for assessing Tourette syndrome in children. Journal of Child and Adolescent Psychopharmacology. 24: 275-84. PMID 24813854 DOI: 10.1089/Cap.2013.0128  0.47
2014 Adams HR, Rose K, Augustine EF, Kwon JM, deBlieck EA, Marshall FJ, Vierhile A, Mink JW, Nance MA. Experience, knowledge, and opinions about childhood genetic testing in Batten disease. Molecular Genetics and Metabolism. 111: 197-202. PMID 24246680 DOI: 10.1016/J.Ymgme.2013.10.017  0.502
2014 Defendorf S, Adams H, Augustine E, Mink J, Marshall F, Vierhile A. The challenges of clinical trials in rare disease: lessons from Batten disease Molecular Genetics and Metabolism. 111: S35. DOI: 10.1016/J.Ymgme.2013.12.065  0.567
2013 Augustine EF, Adams HR, Mink JW. Clinical trials in rare disease: challenges and opportunities. Journal of Child Neurology. 28: 1142-50. PMID 24014509 DOI: 10.1177/0883073813495959  0.575
2013 Augustine EF, Mink JW. Enzyme replacement in neuronal storage disorders in the pediatric population. Current Treatment Options in Neurology. 15: 634-51. PMID 23955157 DOI: 10.1007/S11940-013-0256-3  0.571
2013 Mink JW, Augustine EF, Adams HR, Marshall FJ, Kwon JM. Classification and natural history of the neuronal ceroid lipofuscinoses. Journal of Child Neurology. 28: 1101-5. PMID 23838030 DOI: 10.1177/0883073813494268  0.525
2013 Augustine EF, Blackburn J, Pellegrino JE, Miller R, Mink JW. Myoclonus-dystonia syndrome associated with Russell Silver syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 841-2. PMID 23703955 DOI: 10.1002/Mds.25483  0.442
2013 de Blieck EA, Augustine EF, Marshall FJ, Adams H, Cialone J, Dure L, Kwon JM, Newhouse N, Rose K, Rothberg PG, Vierhile A, Mink JW. Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates. Contemporary Clinical Trials. 35: 48-54. PMID 23628560 DOI: 10.1016/J.Cct.2013.04.004  0.573
2013 Mink J, Augustine EF, Marshall FJ, Adams HR, Kwon JM, Vierhile A, de Blieck EA. The natural history of juvenile Batten disease (JNCL; CLN3 disease) Molecular Genetics and Metabolism. 108: S66. DOI: 10.1016/J.Ymgme.2012.11.170  0.568
2012 Blackburn JS, Mink JW, Augustine EF. Pediatric movement disorders: Five new things. Neurology. Clinical Practice. 2: 311-318. PMID 23634375 DOI: 10.1212/CPJ.0b013e318278bf06  0.514
2012 Cialone J, Adams H, Augustine EF, Marshall FJ, Kwon JM, Newhouse N, Vierhile A, Levy E, Dure LS, Rose KR, Ramirez-Montealegre D, de Blieck EA, Mink JW. Females experience a more severe disease course in Batten disease. Journal of Inherited Metabolic Disease. 35: 549-55. PMID 22167274 DOI: 10.1007/S10545-011-9421-6  0.557
2012 Augustine E, Newhouse N, Adams H, Vierhile A, Kwon J, Marshall F, Mink J. Epilepsy in Juvenile Neuronal Ceroid Lipofuscinosis is Usually Characterized by Well- Controlled Generalized Tonic-Clonic Seizures Molecular Genetics and Metabolism. 105: S18-S19. DOI: 10.1016/J.Ymgme.2011.11.021  0.405
2012 Adams H, Augustine E, Potter S, Kwon J, Marshall F, Newhouse N, Vierhile A, Mink J. Medical Comorbidities in Juvenile Neuronal Ceroid Lipofuscinosis (Batten Disease) Molecular Genetics and Metabolism. 105: S15. DOI: 10.1016/J.Ymgme.2011.11.009  0.522
2012 Cialone J, Adams H, Augustine EF, Marshall FJ, Kwon JM, Newhouse N, Vierhile A, Levy E, Dure LS, Rose KR, Ramirez-Montealegre D, de Blieck EA, Mink JW. Erratum to: Females experience a more severe disease course in batten disease Journal of Inherited Metabolic Disease. 35: 559-559. DOI: 10.1007/S10545-011-9442-1  0.547
2011 Cialone J, Augustine EF, Newhouse N, Vierhile A, Marshall FJ, Mink JW. Quantitative telemedicine ratings in Batten disease: implications for rare disease research. Neurology. 77: 1808-11. PMID 22013181 DOI: 10.1212/Wnl.0B013E3182377E29  0.495
2011 Kwon JM, Adams H, Rothberg PG, Augustine EF, Marshall FJ, Deblieck EA, Vierhile A, Beck CA, Newhouse NJ, Cialone J, Levy E, Ramirez-Montealegre D, Dure LS, Rose KR, Mink JW. Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease). Neurology. 77: 1801-7. PMID 22013180 DOI: 10.1212/Wnl.0B013E318237F649  0.532
2011 Cialone J, Augustine EF, Newhouse N, Adams H, Vierhile A, Marshall FJ, de Blieck EA, Kwon J, Rothberg PG, Mink JW. Parent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data. Journal of Inherited Metabolic Disease. 34: 1075-81. PMID 21556831 DOI: 10.1007/S10545-011-9346-0  0.586
2011 Mink J, Augustine EF, Adams H, Newhouse NJ, Vierhile A, deBlieck EA, Cialone J, Marshall FJ. A phase II, randomized, controlled trial of Mycophenolate Mofetil in children with juvenile NCL (JNCL) Molecular Genetics and Metabolism. 102: S30. DOI: 10.1016/J.Ymgme.2010.11.100  0.423
2011 Adams H, Augustine E, Cialone J, Newhouse N, Vierhile A, deBlieck E, Marshall F, Mink J, Kwon J, Rothberg P. Sex differences in clinical progression and quality of life in juvenile neuronal ceroid lipofuscinosis Molecular Genetics and Metabolism. 102: S3. DOI: 10.1016/J.Ymgme.2010.11.008  0.451
2010 Adams HR, Beck CA, Levy E, Jordan R, Kwon JM, Marshall FJ, Vierhile A, Augustine EF, de Blieck EA, Pearce DA, Mink JW. Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease). Developmental Medicine and Child Neurology. 52: 637-43. PMID 20187884 DOI: 10.1111/J.1469-8749.2010.03628.X  0.532
2010 Mink J, Kwon JM, Marshall FJ, Adams HR, Rothberg PG, deBlieck EA, Vierhile A, Newhouse NJ, Levy EJ, Augustine EF, Ramirez-Montealegre D. 94. The UBDRS predicts rate of JCNL (CLN3) disease progression Molecular Genetics and Metabolism. 99: S27. DOI: 10.1016/J.Ymgme.2009.10.111  0.51
2010 Adams H, Newhouse NJ, Levy EJ, Mink JW, Kwon JM, Marshall FJ, de Blieck E, Vierhile A, Augustine EF, Ramirez-Montealegre D, Adams HR. 2. Visual aid skills and socioeconomic status in children with Batten disease Molecular Genetics and Metabolism. 99: S8. DOI: 10.1016/J.Ymgme.2009.10.019  0.553
2010 Adams H, Newhouse N, Levy EJ, Kwon JM, Marshall FJ, deBlieck EA, Vierhile A, Augustine EF, Ramirez D, Mink JW. 1. Update on longitudinal assessment of children with juvenile neuronal ceroid lipofuscinosis (Batten disease) Molecular Genetics and Metabolism. 99: S8. DOI: 10.1016/J.Ymgme.2009.10.018  0.533
Show low-probability matches.